New criteria for diagnosing, staging Alzheimer’s stirs controversy
By
Kristen Fischer
Jul 01, 2024
The Alzheimer’s Association set out new criteria for diagnosing and staging Alzheimer’s based on recent advancements, especially biomarkers that can biologically detect the disease instead of relying...
Biogen seeks FDA approval for Alzheimer’s drug; aims to be first to slow disease
By
Alicia Lasek
Jul 09, 2020
Treatment with aducanumab reduced declines in memory, language, and activities of daily living performance, the drugmaker says.
Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
Delayed cognitive decline linked to daily use of two languages
By
Alicia Lasek
Sep 21, 2020
People receive a later diagnosis of mild cognitive impairment when they actively speak two languages every day, investigators report.
Clinical briefs for Tuesday, August 1
By
Kristen Fischer
Aug 01, 2023
Vaccine for Alzheimer’s disease gets its start … Free online Parkinson’s course offers information for paid caregivers … Neurologists share tips for Alzheimer’s drugs … Eye experts offer safety...
Clinical briefs for Monday, March 11
By
Kristen Fischer
Mar 11, 2024
FDA holds off on approval for Alzheimer’s drug donanemab … Ageism has overshadowed mental health, experts say … Drug trio best for pain control after hip surgery … Probiotics linked to better cognitive...
Study: Having two copies of gene mutation linked to Alzheimer’s may cause onset
By
Kristen Fischer
May 07, 2024
A new study finds that possessing two copies of a specific gene mutation that’s common in Alzheimer’s disease may be the cause behind the disease in those people.
Elders get a cognitive boost after positive social interactions, mobile study finds
By
Alicia Lasek
Sep 15, 2021
In a smartphone-enabled study, adults aged 70 years and older had better cognitive performance the same day that they reported having more frequent, pleasant social interactions than usual — and on the...
First appropriate use guidance published for Alzheimer’s drug Aduhelm
By
Alicia Lasek
Jul 28, 2021
The new guidelines cover how to choose appropriate patients, safely scale up to a full dose, monitor side effects and assess effectiveness. The authors also address when to stop therapy and what patients...
Clinical Briefs for Tuesday, September 24
By
Alicia Lasek
Sep 23, 2019
Long-term study of nurses links nut consumption with improved health … Alzheimer’s vaccine performs well in phase 2 trial … Gum disease linked to higher risk of hypertension … Simple lifestyle...